Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
3(60%)
Results Posted
100%(2 trials)

Phase Distribution

Ph phase_3
2
40%
Ph not_applicable
1
20%
Ph phase_2
2
40%

Phase Distribution

0

Early Stage

2

Mid Stage

2

Late Stage

Phase Distribution5 total trials
Phase 2Efficacy & side effects
2(40.0%)
Phase 3Large-scale testing
2(40.0%)
N/ANon-phased studies
1(20.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

3

trials recruiting

Total Trials

5

all time

Status Distribution
Active(3)
Completed(2)

Detailed Status

Recruiting3
Completed2

Development Timeline

Analytics

Development Status

Total Trials
5
Active
3
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 22 (40.0%)
Phase 32 (40.0%)
N/A1 (20.0%)

Trials by Status

completed240%
recruiting360%

Recent Activity

3 active trials
Showing 5 of 5
recruitingphase_3

Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer

NCT06958328
completedphase_3

Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer

NCT00936390
recruitingnot_applicable

Biologically-Adapted, Dose-Escalated Radiotherapy for the Treatment of Ewing Sarcoma, BEAR Trial

NCT07188532
recruitingphase_2

Enhanced Local Intensified Radiation Therapy in Elderly Glioblastoma: A Phase 2 Hybrid Randomized Trial

NCT06835803
completedphase_2

Spectroscopic MRI-Guided Radiation Therapy Planning in Glioblastoma

NCT03137888

Clinical Trials (5)

Showing 5 of 5 trials
NCT06958328Phase 3

Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer

Recruiting
NCT00936390Phase 3

Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer

Completed
NCT07188532Not Applicable

Biologically-Adapted, Dose-Escalated Radiotherapy for the Treatment of Ewing Sarcoma, BEAR Trial

Recruiting
NCT06835803Phase 2

Enhanced Local Intensified Radiation Therapy in Elderly Glioblastoma: A Phase 2 Hybrid Randomized Trial

Recruiting
NCT03137888Phase 2

Spectroscopic MRI-Guided Radiation Therapy Planning in Glioblastoma

Completed

All 5 trials loaded

Drug Details

Intervention Type
RADIATION
Total Trials
5